PRESS-RELEASE ·Filed Sep 3, 2026

KMDA

Kamada Ltd.
NEUTRAL
Impact 2/10
Horizondays Processed29d 5h ago WireGlobeNewswire
Press release: dividend
Actionable Insight • Neutral

This is a routine tax administration update with no operational or financial read-through for Kamada. The dividend was already announced in August; the ruling only clarifies withholding tax procedures for certain non-Israeli shareholders. No trading action warranted.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+5d ⚠ clustered
KMDA ▼ -2.69% at T+5d
NEUTRAL call ✗ call lost -2.69% · α vs SPY -1.48% · entry $8.54 → $8.31
Next anchor: T+20d due 13h ago
Latest observation: T+18 -0.53% FF3 residual α
Entry anchored
Sep 3, 04:01 PM ET
via 1-min bar
T+1d
-2.93%
call -2.93% · α -2.38%
$8.29
settled 29d ago
T+5d
-2.69%
call -2.69% · α -1.48%
$8.31
settled 22d ago
T+20d
—
call — · α —
—
due 13h ago
T+60d
—
call — · α —
—
in 8w

Price Chart

Loading chart...

Executive Summary

Kamada announced a tax ruling from the Israel Tax Authority regarding its previously declared $0.17 per share cash dividend (~$9.8M total). The ruling allows certain Nasdaq-traded shareholders resident in treaty countries to potentially receive a reduced Israeli withholding tax rate, subject to documentation requirements. This is a procedural tax matter with no impact on the company's operations or financial performance.

Key Facts

  • Cash dividend of $0.17 per share, totaling approximately $9.8 million, announced August 17, 2026
  • Record date: August 27, 2026; Payment date: September 17, 2026
  • Israel Tax Authority granted a ruling allowing certain Nasdaq shareholders residing in treaty countries to apply for reduced withholding tax rate
  • Standard Israeli withholding tax rate is 30% for substantial shareholders (≥10%) and 25% for others; treaty rates may be lower
  • Shareholders must submit documentation by October 7, 2026 to Tax Agent IBI Trust Management to claim reduced rate
  • Shareholders holding >5% of issued capital or entitled to dividends >$500K cannot get refunds without ITA approval

Financial Impact

Dividend of ~$9.8M total, or $0.17 per share; tax treatment is procedural and does not affect company finances

Risk Factors

  • No material risk — purely procedural tax ruling

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3356236
18 reports for KMDA
Performance horizon
100% Hit rate 8 of 8 directional calls best @ T+20▲ +16.13%Aug 12, 2026
Filters
Rows
Reports for KMDA — sortable, filterable
TypeNow
Sep 16, 2026
16d ago
EFFECT
NEUTRAL ★ 3/10
$8.19 $8.77▲ +7.08%▲ +4.52%$8.20 (+0.12%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 2/10
$7.99 $8.67▲ +8.51%▲ +9.01%$8.20 (+2.63%)
Sep 3, 2026
29d ago
Press Release
NEUTRAL ★ 2/10
$8.54 $8.31▼ −2.69%▼ −1.48%$8.20 (−3.98%)
Sep 3, 2026
29d ago
6-K
NEUTRAL ★ 2/10
$8.54 $8.31▼ −2.69%▼ −1.48%$8.20 (−3.98%)
Aug 17, 2026
6w ago
6-K / PRESS-RELEASE
BULLISH ★ 6/10
$7.76 $8.43▲ +8.63%▲ +9.82%$8.20 (+5.67%)
Aug 12, 2026
7w ago
6-K
BULLISH ★ 6/10
$6.88 $7.89▲ +14.68%▲ +15.12%$8.20 (+19.19%)
Aug 5, 2026
8w ago
6-K
NEUTRAL ★ 2/10
$7.14 $7.26▲ +1.68%▲ +0.47%$8.20 (+14.85%)
Aug 5, 2026
8w ago
6-K
NEUTRAL ★ 2/10
$7.18 $6.88▼ −4.18%▼ −4.53%$8.20 (+14.21%)
Jul 20, 2026
10w ago
6-K
BULLISH ★ 6/10
$7.09 $7.06▼ −0.42%▲ +0.00%$8.20 (+15.66%)
Jul 13, 2026
11w ago
6-K
NEUTRAL ★ 3/10
$7.17 $7.05▼ −1.67%▼ −0.89%$8.20 (+14.37%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (36h 14m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Sep 3, 2026